Català  |  Castellano

Servei de Ginecologia
Hospital Universitari Vall d'Hebron
Àrea Materno-Infantil

Passeig de la Vall d'Hebron, 119-129 - 08035 Barcelona
Telèfon: 93 489 30 00
info@ginecologiavhebron.com
Unitats > Gin. Oncològica i Patologia TGI > Publicacions
Ginecologia Oncològica i Patologia TGI
Publicacions
Publicacions: llibres

1. A. Gil. Tratamiento quirúrgico del cáncer del cuello uterino. A: Cabero Roura Ll, Iglesias Guiu X, Balagueró Lladó Ll, Xercavins Montosa J. XII Curso Intensivo de Formación Continuada en Ginecología Oncológica. Madrid: Ediciones Ergon, S.A.; 2005. p. 101-114. ISBN: 884-8473-334-3.

2. J. Xercavins, A. Gil, Mª A. Pérez-Benavente. Cáncer cervical. Diagnóstico y estadificación. Ganglio centinela. A: Cabero Roura Ll, Iglesias Guiu X, Balagueró Lladó Ll, Xercavins Montosa J. XII Curso Intensivo de Formación Continuada en Ginecología Oncológica. Madrid: Ediciones Ergon, S.A.; 2005. p. 73-78. ISBN: 884-8473-334-3.

3. B. Díaz-Feijoo, A. Gil Moreno, J. Xercavins Montosa. Opciones quirúrgicas en el cáncer de cuello de útero. A: Carreras, Xercavins, Checa. Virus del Papiloma Humano y Cáncer de Cuello de ütero. Madrid: Editorial Médica Panamericana, S.A; 2007. p. 117-130. ISBN: 978-84-9835-101-9.

4. A. Gil. Tratamiento quirúrgico del cáncer del cuello uterino. A: Cabero Roura Ll, Balagueró Lladó Ll, Lailla JM, Xercavins Montosa J. XV Curso Intensivo de Formación Continuada en Ginecología Oncológica y Patología Mamaria. Madrid: Ediciones Ergon, S.A.; 2008. p. 47-60. ISBN: 978-84-8473-676-9.

5. A. Gil-Moreno, Berta Díaz-Feijoo. Tratamiento del cáncer endometrial. A: Cabero Roura Ll, Balagueró Lladó Ll, Lailla JM, Xercavins Montosa J. XV Curso Intensivo de Formación Continuada en Ginecología Oncológica y Patología Mamaria. Madrid: Ediciones Ergon, S.A.; 2008. p. 107-116. ISBN:
978-84-8473-676-9.

6. A. Doll, M. Rigau, M. Abal, M. Monge, E. Colás, M. Llauradó, M. García, H. Alazzouzi, A. Ruíz, M. Amado, J. Castellví, A. García, S. Ramón y Cajal, B. Díaz, A. Gil-Moreno, J. Xercavins, F. Alameda, J. Reventós. XV Curso Intensivo de Formación Continuada en Ginecología Oncológica y Patología Mamaria. Madrid: Ediciones Ergon, S.A.; 2008. p. 129-134. ISBN: 978-84-8473-676-9.

7. A. Gil-Moreno. Càncer de cèrvix y de ovario. Patología del embarazo. A: Cabero Roura Ll, Sánchez Durán MA. Protocolos de Medicina Materno-Fetal (Perinatología), 3ª edición. Madrid: Editorial Ergon; 2008. p. 103-109. ISBN: 978-84-8473-733-9.

8. Gil Moreno A, Doll A, Reventós J, Abal M. Bases moleculares del cáncer ginecológico. A: Cabero Roura Ll. Tratado de Ginecología, Obstetricia y Medicina de la Reproducción. Madrid: Editorial Médica Panamericana; 2011, en prensa.

Publicacions a revista de Factor d'Impacte

1. Gil-Moreno A, Díaz-Feijoo B, Roca I, Puig O, Pérez-Benavente MA, Aguilar I, Martínez-Palones JM, Xercavins J. Total laparoscopic radical hysterectomy with intraoperative sentinel node identification in patients with early invasive cervical cancer. Gynecol Oncol 2005; 96 (1): 187-193.

2. Martín-Ondarza C, Gil-Moreno A, Torres-Cuesta L, García A, Eyzaguirre F, Díaz-Feijoo B, Xercavins J. Endometrial cancer in polyps: A clinical study of 27 cases. Eur J Gynaec Oncol 2005.

3. Martínez-Palones JM, Gil-Moreno A, Pérez-Benavente MA, García-Giménez A, Xercavins J. Umbilical metastasis after laparoscopic retroperitoneal paraaortic lymphadenectomy for cervical cancer: a true port-site metastasis?. Gynecol Oncol 2005; 97 (1): 292-295.

4. Gil-Moreno A, Puig O, Pérez-Benavente MA, Díaz B, Vergés R, De la Torre J, Martínez-Palones JM, Xercavins J. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer. J Minim Invasive Gynecol 2005; 12 (2): 113-20.

5. García A, Castellví J, López M, Gil A, De la Torre J, Ramon y Cajal S. Malignant struma ovarii mimic clear cell carcinoma. Arch Gynecol Obstet 2005; 271 (3): 251

6. Roca I, Caresia AP, Gil-Moreno A, Pifarre P, Aguade-Bruix S, Castell-Conesa J, Martínez-Palones JM, Xercavins J. Usefulness of sentinel lymph node detection in early stages of cervical cancer. Eur J Nucl Med Mol Imaging 2005; 32 (10): 1210-6.

7. Planagumà J, Abal M, Gil-Moreno A, Díaz-Fuertes M, Monge M, García A, Baró T, Xercavins J, Reventós J, Alameda F. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma. J Pathol 2005; 207 (4): 422-9.

8. Díaz-Feijoo B, Gil-Moreno A, Puig O, Martínez-Palones JM, Xercavins J. Total laparoscopic radical trachelectomy with intraoperative sentinel node identification for early cervical stump cancer. J Minim Invasive Gynecol 2005; 12 (6): 522-4.

9. Abal M, Planagumà J, Gil-Moreno A, Monge M, González M, Baró T, García A, Castellví J, Ramon y Cajal S, Xercavins J, Alameda F, Reventós J. Molecular Pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors. Histol Histopathol 2006; 21 (2): 197-204.

10. Castellví J, García A, De la Torre J, Hernández J, Gil A, Xercavins J, Ramon y Cajal S. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentation and angiogenesis. Hum Pathol 2006; 37 (7): 883-9.

11. Gil-Moreno A, Díaz-Feijoo B, Morchón S, Xercavins J. Analysis of survival after laparoscopic-assisted vaginal hysterectomy compared with the conventional abdominal approach for early-stage endometrial carcinoma: a review of the literature. J Minim Invasive Gynecol 2006; 13 (1): 26-35.

12. Cordoba O, Gil-Moreno A, de la Torre J, Martínez-Palones JM, Díaz B, Xercavins J. Extraperitoneal laparoscopic para-aortic lymphadenectomy for lymph node recurrence of fallopian tube carcinoma. Int J Gynecol Cancer 2006; 16 (3): 991-3.

13. Planagumà J, González M, Doll A, Monge M, Gil-Moreno A, Baro T, García A, Xercavins J, Alameda F, Abal M, Reventos J. The up-regulation profiles of p21 /WAF1/CIP1) and RUNX1/AML! correlate with myometrial infiltratic in endometrioid endometrial carcinoma. Hum Pathol 2006; 37 (8): 1050-7.

14. Díaz-Feijoo B, Gil-Moreno A, Xercavins J. Correct terminology regarding total laparoscopic radical surgery means transection of the vagina and closure of the vaginal cuff laparoscopically. J Minim Invasive Gynecol 2006;13 (5): 488-9.

15. Castellví J, García A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, Ramon y Cajal S. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer. 2006;107 (8): 1801-11.

16. Martinez-Palones JM, Pérez-Benavente MA, Gil-Moreno A, Díaz-Feijoo B, Roca I, García-Jiménez A, Aguilar-Martínez I, Xercavins J. Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancer. Gynecol Oncol 2006; 103 (3): 865-70.

17. de la Torre J, García A, Gil-Moreno A, Planagumà J, Reventós J, Cajal SR, Xercavins J. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax). Eur J Obstet Gynecol Reprod Biol 2007; 130(1); 121-128.

18. Martínez-Palones JM, Pérez-Benavente MA, Díaz-Feijoo, B, Gil-Moreno A, Roca I, García-Jiménez A, Aguilar-Martínez I, Xercavins J. Sentinel lymph node identification in a primary ductal carcinoma arising in the vulva. Int J Gynecol Cancer 2007; 17(2): 471-477.

19. Abal M, Llauradó M, Doll A, Monge M, Colas E, González M, Rigau M, Alazzouzi H, Demajo S, Castellví J, García A, Ramón Y Cajal S, Xercavins J, Vázquez-Levin MH, Alameda F, Gil-Moreno A, Reventos J. Molecular determinants of invasion in endometrial cancer. Clin Transl Oncol. 2007; 9(5):272-7.

20. Marta Monge, Eva Colas, Andreas Doll, Marta González, Antonio Gil-Moreno, Jesús Planagumà, Maite Quiles, María Antonia Arbóes, Angel García, Joseph Castellví, Jordi Xercavins, Francesc Alameda, Jaime Reventós, Miguel Abal. ERM/ETV5 up-regulation plays a role during myometrial infiltrataion through MMP-2 activation in endometrial cancer. Cancer Research 2007; 67(14): 6753-9.

21. Antonio Gil-Moreno, Antonio Maffuz, Berta Díaz-Feijoo, Oriol Puig, José M. Martínez-Palones, Asumpció Pérez, Angel García, Jordi Xercavins. Modified Approach for Extraperitoneal Laparoscopic Staging for Locally Advanced Cervical Cancer. J Exp Clin Canc Res 2007; 26(4); 451-8.

22. De la Torre J, Gil-Moreno A, García A, Rojo F, Xercavins J, Salido E, Freire R. Expression of DNA Damage Checkpoint Protein Hus1 in Epithelial Ovarian Tumors Correlates With Prognostic Markers. Int J Gynecol Pathol 2008; 27(1): 24-32.

23. Díaz-Feijoo B, Gil-Moreno A, Pérez-Benavente MA, Puig O, Aguilar I, Martínez-Palones JM, Xercavins J. Sentinel node identification and radical hysterectomy with lymphadenectomy in early stage cervical cancer: morbidity and survival after laparoscopy versus laparotomy. J Minim Invasive Gynecol 2008; 15(5): 531-7.

24. Prat A, Parera M, Peralta S, Pérez-Benavente MA, García A, Gil-Moreno A, Martínez-Palones JM, Roxana I, Baselga J, Del Campo JM. Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer. Ann Oncol 2008; 19: 327-331.

25. Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colás E, Llauradó M, Alazzouzi H, Planagumá J, Lohmann MA, Garcia J, Castellvi S, Cajal JR, Gil-Moreno A, Xercavins J, Alameda F, Reventós J. Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol. 2008; 108(3-5): 221-229.

26. Prat A, Parera M, Adamo B, Peralta S, Pérez-Benavente MA, García A, Gil-Moreno A, Martínez-Palones JM, Baselga J, Del Campo JM. Risk of Recurrence during Follow-up for Optimally Treated Advanced Epithelial Ovarian Cancer (EOC) with a Low-Level Increase of Serum CA-125 Levels. Ann Oncol 2009; 20: 294-297.

27. Gil-Moreno A, Díaz-Feijoo B, Pérez-Benavente A, del Campo JM, Xercavins J, Martínez-Palones JM. Impact of retroperitoneal lymphadenectomy on treatment and survival in patients with locally advanced cervical cancer. Gynecol Oncol 2008; 110: s33-s35.

28. Gil-Moreno A, Franco-Camps S, Díaz-Feijoo B, Pérez-Benavente A, Martínez-Palones JM, del Campo JM, Parera M, Vergés R, Castellví J, Xercavins J. Usefulness of extraperitoneal laparoscopic paraaaortic lymphadenectomy for lymph node recurrence in gynecologic malignancy. Acta Obstet Gynecol Scand 2008; 87(7): 723-30.

29. Cabrera Díaz S, Díaz-Feijoo B, Gil-Moreno A, Martínez-Palones JM, Xercavins J. Mucocele of the appendix. J Minim Invasive Gynecol 2008;15(2):130-1.

30. Andreas Doll, Marta González, Miguel Abal, Marta Llauradó, Marina Rigau, Eva Colas, Marta Monge, Jordi Xercavins, Gabriel Capella, Berta Díaz, Antonio Gil-Moreno, Francesc Alameda, Jaime Reventós. An orthotopic endometrial cancer mouse model demostrates a role for RUNX1 in distant metastasis. Int J Cancer 2009; 125: 257-263.

31. Castellví J, García A, Ruiz-Marcellan C, Hernández-Losa J, Peg V, Salcedo M, Gil-Moreno A, Cajal SR. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlatos with aggressive tumors and prognosis. Hum Pathol 2009; 40(10): 1418-26.

32. Monge M, Colas E, Doll A, Gil-Moreno A, Castellvi J, Diaz B, Gonzalez M, Lopez-Lopez R, Xercavins J, Carreras R, Alameda F, Canals F, Gabrielli F, Reventos J, Abal M. Proteomic approach to ERM/ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress. Carcinogenesis 2009; 30(8): 1288-97.

33. Monge M, Doll A, Colas E, Gil-Moreno A, Castellvi J, Garcia A, Colome N, Perez-Benavente A, Pedrola N, Lopez-Lopez R, Dolcet X, Ramon Y Cajal S, Xercavins J, Matias-Guiu X, Canals F, Reventos J, Abal M. Subtractive proteomic approach to the endometrial carcinoma invasion front. J Proteome Res. 2009, 8: 4676-4684.

34. Cabrera S, Franco-Camps S, García A, Vergés R, Díaz-Feijoo B, Pérez-Benavente MA, Poza JL, Bradbury M, Xercavins J, Gil-Moreno A. Total laparoscopic radical hysterectomy for cervical cancer in prolapsed uterus. Arch Gynecol Obstet 2010; 282: 63-67.

35. Mancebo G, Gil-Moreno A, Vergés R, Martínez-Palones JM, Checa MA, Carreras JM, Giralt J, Xercavins J. Out-of-protocol concurrent use of cisplatin and radiation therapy in locally advanced cervical cancer: feasibility and survival. Eur J Gynaecol Oncol. 2010;31(1):18-22.

36. Silvia Franco-Camps, Silvia Cabrera-Díaz, Assumpció Pérez-Benavente, Berta Díaz-Feijoo, Melisa Bradbury , Jordi Xercavins, Antonio Gil-Moreno. Extraperitoneal Laparoscopic approach for diagnosis and treatment of aortic lymph node recurrence in gynecologic malignancy. J Minim Invasive Gynecol 2010, 17(5):570-575.

37. Antonio Gil-Moreno, Silvia Cabrera-Díaz, Assumpció Pérez-Benavente, Silvia Franco-Camps, Xavier Martínez-Gómez, Angel García and Jordi Xercavins. Usefulness of extraperitoneal laparoscopic para-aortic lymphadenectomy on treatment and survival in patients with locally advanced cervical cancer. Ann Surg Oncol. 2011 Feb;18(2):482-9. Epub 2010 Sep 14.

38. Eva Colas, Cristina Pérez, Silvia Cabrera-Díaz, Nuria Pedrola, Marta Monge, Josep Castellví, Fernando Eyzaguirre, Jesús Gregorio, Anna Ruiz, Rafael Lópe-López, Ramón Carreras, Jordi Xercavins, Alicia Ortega, Elisabet Rosell, Andreas Doll, Miguel Abal, Jaume Reventós, Antonio Gil-Moreno. Molecular markers of endometrial carcinoma detected in uterine aspirates. Int J Cancer. 2011 Jan 4. [Epub ahead of print]

39. Cabrera S, Gil-Moreno A. Reply to "Pretherapeutic Laparoscopic Paraaortic Staging in Advanced Cervical Cancer-Which Patients Should Be Considered?". Ann Surg Oncol. 2010 Dec 21. [Epub ahead of print]

40. Díaz-Feijoo B, Pérez-Benavente MA, Cabrera-Diaz S, Gil-Moreno A, Roca I, Franco-Camps S, Fernández MS, García-Jiménez A, Xercavins J, Martínez-Palones JM. Change in clinical management of sentinel lymph node location in early stage cervical cancer. The role of SPECT/CT. Gynecol Oncol. 2011 Mar;120(3):353-7. Epub 2011 Jan 6.